<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The article presents the findings of the Encefabol treatment of 50 patients aged 56-68 yy with vascular <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> at the I-III stage, caused by atherosclerotic and <z:mp ids='MP_0002842'>high blood pressure</z:mp> pathological processes </plain></SENT>
<SENT sid="1" pm="."><plain>The individual dose prescription of the medication to patients with vascular <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> was substantiated in the article </plain></SENT>
<SENT sid="2" pm="."><plain>The importance of psychodiagnostic tests in assessment of Encefabol treatment efficiency of the disease was shown in the article </plain></SENT>
</text></document>